Correlation Between Molecular Partners and Revelation Biosciences

Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Molecular Partners AG and Revelation Biosciences, you can compare the effects of market volatilities on Molecular Partners and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Revelation Biosciences.

Diversification Opportunities for Molecular Partners and Revelation Biosciences

0.42

Correlation Coefficient

Molecular Partners  Revelation Biosciences

Very weak diversification

The 3 months correlation between Molecular and Revelation is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Molecular Partners i.e., Molecular Partners and Revelation Biosciences go up and down completely randomly.

Pair Corralation between Molecular Partners and Revelation Biosciences

Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.66 times more return on investment than Revelation Biosciences. However, Molecular Partners AG is 1.52 times less risky than Revelation Biosciences. It trades about 0.02 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.06 per unit of risk. If you would invest  693.00  in Molecular Partners AG on August 31, 2024 and sell it today you would lose (111.00) from holding Molecular Partners AG or give up 16.02% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.73%
Values	Daily Returns

Molecular Partners AG  vs.  Revelation Biosciences

Molecular Partners

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.

Revelation Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Revelation Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Molecular Partners and Revelation Biosciences

The main advantage of trading using opposite Molecular Partners and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.

The idea behind Molecular Partners AG and Revelation Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.